 |
|
Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease
P. Michael Ho, MD, PhD;
David J. Magid, MD, MPH;
Susan M. Shetterly, MS;
Kari L. Olson, PharmD, BCPS;
Pamela N. Peterson, MD, MPH;
Frederick A. Masoudi, MD, MPH;
John S. Rumsfeld, MD, PhD
Arch Intern Med. 2008;168(3):271-276.
Background Despite the importance of blood pressure (BP) control in secondary prevention, a significant proportion of patients with coronary disease have uncontrolled BP.
Methods This retrospective cohort study of patients with coronary disease (N = 10 447) evaluated the impact of medication nonadherence and therapy intensification on reaching target BP goals. Medication adherence was calculated as the proportion of days covered for filled prescriptions of antihypertensive medications. Therapy intensification included dosage increase or increase in number of antihypertensive medications. The primary outcome was uncontrolled systolic BP (SBP) over time, using a latent class model that incorporated longitudinal SBP data and assigned patients to SBP trajectory groups. Multivariable regression evaluated the association between medication nonadherence (ie, proportion of days covered, <0.80) and therapy intensification with SBP control over time, with adjustment for demographics and clinical characteristics.
Results Three SBP trajectory groups were identified: (1) patients with BP that remained controlled (ie, SBP,  140 mm Hg) over time (n = 9114 [87.2%]); (2) patients with high BP that became controlled (n = 779 [7.5%]); and (3) patients with BP that remained high over time (n = 554 [5.3%]). In multivariable analyses, therapy intensification (odds ratio, 1.31; 95% confidence interval, 1.01-1.70) and medication nonadherence (odds ratio, 1.73; 95% confidence interval, 1.34-2.24) were associated with uncontrolled BP compared with high SBP that became controlled over time.
Conclusions These findings suggest that medication nonadherence can help explain why BP levels remained elevated despite intensification of antihypertensive medications. Successful BP control is seen with a combination of intensification and adherence, suggesting that therapy intensification must be coupled with interventions to enhance medication adherence.
Author Affiliations: Cardiology Section, Denver Veterans Affairs Medical Center, Denver, Colorado (Drs Ho and Rumsfeld); Departments of Medicine (Drs Ho, Peterson, Masoudi, and Rumsfeld) and Preventive Medicine and Biometrics (Dr Magid), University of Colorado Health Sciences Center, Denver; Department of Medicine, Denver Health Medical Center (Drs Peterson and Masoudi); and Institute for Health Research (Drs Ho, Magid, Peterson, Masoudi, and Rumsfeld and Ms Shetterly) and Department of Pharmacy and Clinical Pharmacy Cardiac Risk Service (Dr Olson), Kaiser Permanente of Colorado, Aurora.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Importance of Perception for Blood Pressure Control
Vivencio Barrios, Carlos Escobar, Vicente Bertomeu, Nekane Murga, Carmen de Pablo, and Alberto Calderón
Arch Intern Med. 2008;168(17):1928.
EXTRACT
| FULL TEXT
Medication Nonadherence for Blood Pressure Control Is Primarily a Physician-Related Factor
Randy Wexler and David Feldman
Arch Intern Med. 2008;168(17):1928-1929.
EXTRACT
| FULL TEXT
Medication Nonadherence for Blood Pressure Control Is Primarily a Physician-Related Factor—Reply
P. Michael Ho and David J. Magid
Arch Intern Med. 2008;168(17):1929.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Is Information the Answer for Hypertension Control?
Eric D. Peterson
Arch Intern Med. 2008;168(3):259-260.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Intensifying Therapy for Hypertension Despite Suboptimal Adherence
Rose et al.
Hypertension 2009;54:524-529.
ABSTRACT
| FULL TEXT
Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy
Benner et al.
Am J Health Syst Pharm 2009;66:1471-1477.
ABSTRACT
| FULL TEXT
Withdrawal of Statins and Risk of Subarachnoid Hemorrhage
Risselada et al.
Stroke 2009;40:2887-2892.
ABSTRACT
| FULL TEXT
Comparing Methods of Measuring Treatment Intensification in Hypertension Care
Rose et al.
Circ Cardiovasc Qual Outcomes 2009;2:385-391.
ABSTRACT
| FULL TEXT
Globalization of Blood Pressure Control
Escobar and Barrios
Arch Intern Med 2009;169:314-315.
FULL TEXT
Importance of Perception for Blood Pressure Control
Barrios et al.
Arch Intern Med 2008;168:1928-1928.
FULL TEXT
Medication Nonadherence for Blood Pressure Control Is Primarily a Physician-Related Factor--Reply
Ho and Magid
Arch Intern Med 2008;168:1929-1929.
FULL TEXT
Medication Nonadherence for Blood Pressure Control Is Primarily a Physician-Related Factor
Wexler and Feldman
Arch Intern Med 2008;168:1928-1929.
FULL TEXT
Patient Adherence and Treatment Intensification in Hypertension Management
Journal Watch Cardiology 2008;2008:1-1.
FULL TEXT
Is Information the Answer for Hypertension Control?
Peterson
Arch Intern Med 2008;168:259-260.
FULL TEXT
|
